1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Acute Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinden, R; Zhang, X | 1 |
| Cao, MH; Chen, CJ; Feng, YJ; Han, T; Li, K; Li, YY; Lin, XH; Xu, J | 1 |
| Agarwal, N; Bátkai, S; Bergmann, F; Friess, H; Giese, NA; Giese, T; Kuner, R; Laukert, T; Michalski, CW; Pacher, P; Sauliunaite, D; Su, Y | 1 |
| Bari, M; Battistini, L; Bernardi, G; Bernardini, S; Centonze, D; De Chiara, V; Fezza, F; Furlan, R; Maccarrone, M; Martino, G; Prosperetti, C; Rossi, S | 1 |
| Achiron, A; Biegon, A; Lavie, V; Margalit, R; Miron, S | 1 |
| Bountra, C; Clayton, N; Marshall, FH; O'Shaughnessy, CT | 1 |
6 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Acute Disease
| Article | Year |
|---|---|
Cannabinoids & Stress: impact of HU-210 on behavioral tests of anxiety in acutely stressed mice.
Topics: Acute Disease; Animals; Anti-Anxiety Agents; Anxiety; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Motor Activity; Random Allocation; Receptor, Cannabinoid, CB1; Stress, Psychological | 2015 |
Cannabinoid HU210 protects isolated rat stomach against impairment caused by serum of rats with experimental acute pancreatitis.
Topics: Acute Disease; Animals; Antiemetics; Cannabinoids; Cells, Cultured; Cytoprotection; Disease Models, Animal; Dronabinol; Lipopolysaccharides; Male; Organ Culture Techniques; Pancreatitis; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Serum; Stomach | 2012 |
Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
Topics: Acute Disease; Animals; Biopsy; Cannabinoid Receptor Modulators; Cannabinoids; Ceruletide; Dronabinol; Female; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Pain; Pancreas; Pancreatitis; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2007 |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.
Topics: Acute Disease; Adult; Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Corpus Striatum; Disease Models, Animal; Dronabinol; Electrophysiology; Encephalomyelitis, Autoimmune, Experimental; Endocannabinoids; Female; Glycerides; Humans; Lymphocytes; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroprotective Agents; Patch-Clamp Techniques; Polyunsaturated Alkamides; Synaptic Transmission; Tissue Culture Techniques | 2007 |
Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis.
Topics: Acute Disease; Animals; Brain; Dose-Response Relationship, Drug; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Female; Injections, Intraperitoneal; Injections, Intravenous; Multiple Sclerosis; Neuroprotective Agents; Rats; Rats, Inbred Lew; Recurrence; Spinal Cord; Time Factors; Treatment Outcome | 2000 |
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
Topics: Acute Disease; Animals; Camphanes; Cannabinoids; Carrageenan; Dronabinol; Hypersensitivity; Indoles; Male; Morpholines; Neurogenic Inflammation; Nociceptors; Pain; Pyrazoles; Rats; Rats, Inbred Strains; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug | 2002 |